Cargando…
Does inhaled corticosteroid use affect the risk of COVID-19-related death?
ICS does not seem to protect against COVID-19-related mortality, but more data is needed to determine whether it is harmful. Due to its known and important benefits ICS should be prescribed as usual for both asthma and COPD. https://bit.ly/3pWVimX
Autores principales: | Jordan, Alexander, Sivapalan, Pradeesh, Jensen, Jens-Ulrik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8291911/ https://www.ncbi.nlm.nih.gov/pubmed/34295392 http://dx.doi.org/10.1183/20734735.0275-2020 |
Ejemplares similares
-
Withdrawal of inhaled corticosteroids in COPD patients: rationale and algorithms
por: Avdeev, Sergey, et al.
Publicado: (2019) -
Time-Updated Phenotypic Guidance of Corticosteroids and Antibiotics in COPD: Rationale, Perspective and a Proposed Method
por: Jordan, Alexander, et al.
Publicado: (2023) -
Using Blood Eosinophil Count as a Biomarker to Guide Corticosteroid Treatment for Chronic Obstructive Pulmonary Disease
por: Sivapalan, Pradeesh, et al.
Publicado: (2021) -
Inhaled corticosteroids and risk of lower respiratory tract infection with Moraxella catarrhalis in patients with chronic obstructive pulmonary disease
por: Johnsen, Rikke Helin, et al.
Publicado: (2023) -
Acute exacerbations of idiopathic pulmonary fibrosis and the role of corticosteroids
por: Brereton, Christopher J., et al.
Publicado: (2020)